Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in...

Area of Science:

• Cardiology
• Hematology
• Clinical Trials

Background:

• Neutrophils play a role in inflammation and tissue injury.
• Elevated neutrophil counts are observed in various cardiovascular conditions.

Purpose of the Study:

• To examine the relationship between baseline neutrophil count and clinical outcomes in ST-elevation myocardial infarction (STEMI).
• To assess the impact of neutrophil count on the efficacy of clopidogrel therapy in STEMI patients.

Main Methods:

• Analysis of data from the CLARITY-TIMI 28 randomized trial involving 2865 STEMI patients.
• Baseline neutrophil counts were correlated with angiographic findings, cardiovascular death, and heart failure at 30 days.
• Statistical adjustments were made for relevant clinical and demographic factors.

Main Results:

• Higher baseline neutrophil counts were independently associated with increased 30-day cardiovascular death and congestive heart failure.
• Increased neutrophil counts correlated with poorer ST-segment resolution and reduced myocardial perfusion.
• The benefit of clopidogrel in reducing adverse events was significantly diminished in patients with neutrophil counts above the median.

Conclusions:

• Elevated baseline neutrophil count is a significant predictor of adverse outcomes in STEMI.
• Higher neutrophil counts are linked to unfavorable angiographic results and increased mortality.
• Neutrophil count may influence the effectiveness of antiplatelet therapy, such as clopidogrel, in STEMI management.